AST's Matthew Gorton offers insights on solutions to common problems in small batch production
Overcome the Challenges of Small Batch Production While Maximizing Yield
by Matthew Gorton, Automated Systems of Tacoma
A focus on niche drugs for targeted patient populations has led to an increase in small batch production across the pharmaceutical industry. These products include advanced therapy medicinal products (ATMPs) and high-value biologics that require very complex production processes or the use of expensive active pharmaceutical ingredients APIs) that are often limited in supply. A minimal amount available poses major challenges when filling a product, making process efficiency a critical factor in reducing waste and improving the yield for small batches of drug product.
To read or download the full article, please click the link below: